TALPHERA, INC. TLPH
Nasdaq · stock · Pharmaceutical Preparations · website · IPO 2011-02-11
TALPHERA, INC. statistics & valuation
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports.
Profitability & efficiency
Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating margin | -48157.1% | — | -2594.3% | — | -1276.3% | -756.3% | -2368.1% | -1660.9% | -483.8% | -184.1% |
| Net margin | -51035.7% | — | -2826.0% | — | -1245.5% | -745.6% | -2325.9% | -2192.0% | -644.3% | -248.6% |
| FCF margin | — | — | -2702.3% | — | -1129.5% | -745.2% | -2387.5% | -1389.8% | -402.4% | -190.8% |
| Return on assets | -48.1% | -71.3% | -90.2% | 100.6% | -45.1% | -60.9% | -58.3% | -39.1% | -68.2% | -43.2% |
| Return on equity | -83.9% | -162.5% | -130.4% | 218.9% | 97.8% | 72.4% | 128.5% | -1108.6% | 141.1% | 808.6% |
| Debt / equity | — | — | — | 0.26× | -0.38× | -0.39× | -0.61× | 2.82× | -0.52× | -4.04× |
| Current ratio | 5.49 | 3.56 | 2.57 | 1.78 | 2.73 | 2.66 | 5.27 | 6.78 | 4.64 | 8.74 |
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.